![](/img/cover-not-exists.png)
Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug Design
Robert M. Immormino, Louis E. Metzger IV, Patrick N. Reardon, D. Eric Dollins, Brian S.J. Blagg, Daniel T. GewirthVolume:
388
Year:
2009
Language:
english
DOI:
10.1016/j.jmb.2009.03.071
File:
PDF, 2.08 MB
english, 2009